Clinical Trials Logo

Clinical Trial Details — Status: Completed

Administrative data

NCT number NCT05616455
Other study ID # EMOR
Secondary ID
Status Completed
Phase Phase 4
First received
Last updated
Start date October 1, 2021
Est. completion date May 31, 2022

Study information

Verified date November 2022
Source Treviso Regional Hospital
Contact n/a
Is FDA regulated No
Health authority
Study type Interventional

Clinical Trial Summary

The study compares the efficacy and safety of a Propionibacterium extract gel with 0.4% glyceryl trinitrate ointment in the treatment of chronic anal fissure.


Description:

Patients were randomly allocated to a PeG or GTN group and medication was taken every 12 hours for 40 days. Primary outcome was the success rate as measured by a decrease in the REALISE score at 10, 20 and 40 days after starting either treatment. The secondary out-comes were the healing rate, the partial or complete resolution of itching and burning, the rate of complications and adverse events, patients' quality of life and satisfaction at the same time points.


Recruitment information / eligibility

Status Completed
Enrollment 120
Est. completion date May 31, 2022
Est. primary completion date March 31, 2022
Accepts healthy volunteers No
Gender All
Age group N/A and older
Eligibility Inclusion Criteria: - Consecutive patients diagnosed with chronic anal fissure aged between 18 and 75 years Exclusion Criteria: - Fecal incontinence - Inflammatory bowel disease - Previous history of anal surgery - Previous or concomitant treatment for anal fissure, sexually transmitted disease, cancer, immune-suppressive treatment - Current pregnancy or breastfeeding - Known allergy to one of the agents contained into the evaluating drugs

Study Design


Related Conditions & MeSH terms


Intervention

Drug:
Propionibacterium Acnes
Application of the gel every 12 hours for 40 days
glyceryl trinitrate
Application of the gel every 12 hours for 40 days

Locations

Country Name City State
Italy Regional Hospital Treviso Treviso

Sponsors (1)

Lead Sponsor Collaborator
Treviso Regional Hospital

Country where clinical trial is conducted

Italy, 

Outcome

Type Measure Description Time frame Safety issue
Primary REALISE score REALISE (scoRing systEm for AnaL fIsSurE), was used to assess pain (minimum score = 0, maximum score = 10) From baseline to visit 3 (40 days after the start of the treatment)
Secondary Burning Visual analogue scale (VAS) (minimum score = 0, maximum score = 10) From baseline to visit 3 (40 days after the start of the treatment)
Secondary Itching Visual analogue scale (VAS) (minimum score = 0, maximum score = 10) From baseline to visit 3 (40 days after the start of the treatment)
Secondary Epithelialization The degree of epithelialization of the fissure was determined at each visit and stratified using 3 levels (1 to 3) corresponding to <50%, >50% of healing or complete healing, respectively. From baseline to visit 3 (40 days after the start of the treatment)
Secondary Physical and mental health Short-Form 12 (SF-12) From baseline to visit 3 (40 days after the start of the treatment)
Secondary Physical and mental health SF-36 - Physical component score (PCS) At visit 3 (40 days after the start of the treatment)
Secondary Physical and mental health SF-36 - Mental component score (MCS) At visit 3 (40 days after the start of the treatment)
Secondary Patients' satisfaction VAS (1 = unsatisfied; 2 = neutral; 3 = quite satisfied; 4 = very satisfied; 5 = extremely satisfied) At visit 3 (40 days after the start of the treatment)
See also
  Status Clinical Trial Phase
Completed NCT06216223 - Laser Versus Surgery in Anal Diseases in Inflammatory Bowel Patients N/A
Not yet recruiting NCT05405634 - Microbiota in Chronic Anal Fissure and Its Association With Prognosis
Completed NCT05736926 - Anal Fissure Among Survivors of COVID-19 Virus Infection.
Enrolling by invitation NCT00980369 - The Importance of Lateral Internal Sphincterotomy Incision: Parallel or Vertical N/A
Completed NCT04173130 - Monocentric Feasibility Study for a New Medical Device for the Treatment of Anal Fissure With Botulinum Toxin N/A
Completed NCT03345511 - Ultrasound Guided Caudal Block for Benign Anal Surgery N/A
Completed NCT05341180 - Efficacy of Polyethylene Glycol vs Lactulose With Isabgol in Acute Fissure-in-Ano: PEGASIS Trial Phase 2/Phase 3
Completed NCT03528772 - Topical Minoxidil Versus Topical Glyceryl Trinitrate in Treatment of Chronic Anal Fissure N/A
Active, not recruiting NCT04428697 - Sungurtekin Technique vs. Closed Lateral Internal Sphincterotomy Technique N/A
Terminated NCT02023047 - An Open Label Multi-Dose Study to Examine the Effect of Coated Nifedipine Suppository on Anal Fissure Pain and Healing Phase 1/Phase 2
Withdrawn NCT01920074 - Pharmacokinetic,Safety and Exploratory Efficacy of RECTIV® in Adolescents With Chronic Anal Fissure Phase 4
Recruiting NCT01039051 - Diet and Lifestyle Intervention Study in Postpartum Women in China Phase 2/Phase 3
Completed NCT00210444 - Efficacy Study of Dysport® in the Treatment of Anal Fissure. Phase 2
Completed NCT00827736 - Comparison of Treatment Success of Botox Injection in the Internal Sphincter Versus Isosorbidedinitrate Ointment in Patients With an Anal Fissure Phase 4
Withdrawn NCT02667535 - PK, PD and Safety Comparative Trial of Isosorbide Mononitrate Gel in Healthy Participants and With Anal Fissure Phase 1
Not yet recruiting NCT06049524 - Could Preoperative Assessment of Physical and Psychological Status Help Predict Pain After Anorectal Surgery?
Not yet recruiting NCT05709717 - Regenerative Therapy With Autologous Stromal Vascular Fraction Derived Mesenchymal Stem Cells and Platelet-rich Plasma to Treat Complex Perianal Diseases
Completed NCT05038605 - Topical vs Oral Metronidazole After Benign Anorectal Surgery N/A
Not yet recruiting NCT03780998 - Effects of Sodium Pentaborat Based Gel on Perianal Benign Diseases
Completed NCT03426449 - Posterolateral Versus Lateral Internal Anal Sphincterotomy for Chronic Anal Fissure N/A